|
Delayed
OTC Markets
16:46:53 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0220 USD | -15.38% |
|
-21.43% | -15.38% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Biopharmaceuticals | -15.38% | -21.43% | -15.38% | -56.86% | -99.65% | 6.89M |
-
|
-
|
-
|
- Stock Market
- Stocks
- ADAPY Stock
- Charts Adaptimmune Therapeutics plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
